Dive in

We’re thrilled to lead OfferFit’s Series B and believe it delivers a category-disrupting solution at a time when the marketing world is looking to embrace AI.

Eleos is the leader in CareOps Automation for behavioral health and joins Menlo Ventures’ exciting portfolio of healthcare software and AI companies.

With Cleanlab, AI teams automate weeks of manual data labeling and bypass dozens of engineering hours for model training and deployment.

Predictive and generative AI are entering many new applications. At Menlo Ventures, we are especially excited about applications for AI in drug discovery and development, specifically when new technology can directly address a major unmet need.

Joff joins our team of deep and complementary operators and, in particular, adds world-class expertise in finding product-market fit and scaling product organizations.

Drug design is both a natural fit and a unique challenge for generative AI, given large but messy datasets, time and cost of real-world testing, and the complexity of human trials.

While navigating this exciting yet complex landscape may seem daunting for startups, lessons from past tech waves, along with a thoughtful, strategic approach, can help illuminate the path forward.

We stand on the precipice of an extraordinary platform shift catalyzed by groundbreaking advancements in generative artificial intelligence.

Genesis Therapeutics is pioneering AI technologies to create medicines for patients with severe and unmet medical needs.

Retail e-commerce is as old as the advent of the web. In the decades that followed, a wave of innovation across supply chain, logistics, advertising, payments, checkout, and storefront tech has vastly improved the consumer e-commerce experience.

OpenAI’s ChatGPT reached 100 million monthly active users just two months after launch, setting the new standard for the fastest-growing consumer application in history. The landmark achievement underscored the strength of generative AI’s pull in consumer markets—surpassing even the breakthroughs of the internet and smartphones.

Pinecone has raised a $100M Series B led by A16Z—with explosive growth justifying their new $750M valuation.

Recursion is a breakthrough drug discovery company that combines a novel computer vision platform with deep disease biology and chemistry.

Since the advent of the internet, few technological advances have garnered as much attention and enthusiasm as quickly as generative AI.

There’s been a seismic shift in the environment for learning and training on the job.

RAI has created perhaps one of the most unique and powerful databases in the world.